132 Live Attenuated Malaria Vaccine Designed to Protect Through Hepatic CD8+ T Cell Immunity.
http://www.sciencemag.org/content/334/6055/475.abstract
131 A neutralizing human monoclonal antibody can fully protect nonhuman primates from disease after a lethal Hendra virus challenge.
http://stm.sciencemag.org/content/3/105/105ra103.abstract
130 Mitochondrial antiviral signaling protein (MAVS) monitors commensal bacteria and induces an immune response that prevents experimental colitis.
http://www.pnas.org/content/108/42/17390.abstract
129 Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells.
http://www.pnas.org/content/108/42/17384.abstract
128 Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage.
http://www.pnas.org/content/108/42/17372.abstract
127 Vitamin D Is Required for IFN-γ–Mediated Antimicrobial Activity of Human Macrophages.
http://stm.sciencemag.org/content/3/104/104ra102
126 Human TH17 Cells Are Long-Lived Effector Memory Cells.
http://stm.sciencemag.org/content/3/104/104ra100
125 Protection against the toxic effects of Loxosceles intermedia spider venom elicited by mimotope peptides.
http://www.sciencedirect.com/science/article/pii/S0264410X11013119
124 Protective immunity to ricin toxin conferred by antibodies against the toxin's binding subunit (RTB).
http://www.sciencedirect.com/science/article/pii/S0264410X1101334X
123 CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates. Nancy Sullivan et al. report that the protective efficacy of a recombinant Ad5-based Ebola virus vaccine relies primarily on CD8+ T cells rather than on antibodies. The findings suggest that clinical development of T cell–based vaccines against Ebola virus is warranted.
http://www.nature.com/nm/journal/v17/n9/abs/nm.2447.html
|
